Evidence map›Paper›PMID 36661737›Full record

ReviewCurrent oncology (Toronto, Ont.)2023

Different Re-Irradiation Techniques after Breast-Conserving Surgery for Recurrent or New Primary Breast Cancer.

Camille Hardy Abeloos, Juhi M Purswani, Paulina Galavis, Allison McCarthy, Christine Hitchen, J Isabelle Choi, Naamit K Gerber

Abstract readReview
In one paragraph

Review in Current oncology (Toronto, Ont.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Evaluation of normal tissue complications in breast cancer re-irradiation: a meta-analysis study.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Evaluation of tattoo reliability in breast cancer re-irradiation.Technical innovations & patient support in radiation oncology · 2025
    Article
  6. Review
  7. Moderately hypofractionated partial breast reirradiation: early clinical results and dosimetric considerations in the context of 2Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Review
  8. Review
  9. Review
  10. Article
  11. The Coming of Age of Breast Radiotherapy.Current oncology (Toronto, Ont.) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Camille Hardy AbeloosDepartment of Radiation Oncology, NYU School of Medicine, New York, NY 10016, USA.
Juhi M PurswaniDepartment of Radiation Oncology, NYU School of Medicine, New York, NY 10016, USA.ORCID 0000-0003-1068-9449
Paulina GalavisDepartment of Radiation Oncology, NYU School of Medicine, New York, NY 10016, USA.
Allison McCarthyDepartment of Radiation Oncology, NYU School of Medicine, New York, NY 10016, USA.
Christine HitchenDepartment of Radiation Oncology, NYU School of Medicine, New York, NY 10016, USA.
J Isabelle ChoiDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Naamit K GerberDepartment of Radiation Oncology, NYU School of Medicine, New York, NY 10016, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Breast re-irradiation (reRT) after breast-conserving surgery (BCS) using external beam radiation is an increasingly used salvage approach for women presenting with recurrent or new primary breast cancer. However, radiation technique, dose and fractionation as well as eligibility criteria differ between studies. There is also limited data on efficacy and safety of external beam hypofractionation and accelerated partial-breast irradiation (APBI) regimens. This paper reviews existing retrospective and prospective data for breast reRT after BCS, APBI reRT outcomes and delivery at our institution and the need for a randomized controlled trial using shorter courses of radiation to better define patient selection for different reRT fractionation regimens.

Indexed as

Breast NeoplasmsRe-IrradiationFemaleHumansMastectomy, SegmentalProspective StudiesRetrospective Studiesbreast re-irradiationeligibilityoutcometoxicity

Identifiers

PMID36661737
PMCPMC9857440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.